Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease

Published:2017-10 Issue:10 Volume:6 Page:1254-1263
ISSN:2212-8778
Container-title:Molecular Metabolism
language:en
Short-container-title:Molecular Metabolism

Author:

Baumeier Christian,Schlüter Luisa,Saussenthaler Sophie,Laeger Thomas^ORCID,Rödiger Maria,Alaze Stella Amelie,Fritsche Louise^ORCID,Häring Hans-Ulrich,Stefan Norbert^ORCID,Fritsche Andreas,Schwenk Robert Wolfgang,Schürmann Annette^ORCID

Funder

Ministry of Education and Research

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference48 articles.

1. Nonalcoholic fatty liver disease: a systematic review;Rinella;JAMA,2015

2. Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American association for the study of liver Diseases-U.S. Food and drug administration joint workshop;Sanyal;Hepatology,2015

3. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological association, American association for the study of liver diseases, and American College of Gastroenterology;Chalasani;Gastroenterology,2012

4. DPP4 in diabetes;Röhrborn;Frontiers in Immunology,2015

5. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders;Gorrell;Clinical Science (London),2005

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adipose tissue in older individuals: a contributing factor to sarcopenia;Metabolism;2024-11

2. Sodium‐glucose co‐transporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors on major liver outcomes in metabolic dysfunction‐associated steatotic liver disease;Diabetes, Obesity and Metabolism;2024-08-12

3. Epigallocatechin gallate alleviates non-alcoholic fatty liver disease through the inhibition of the expression and activity of Dipeptide kinase 4;Clinical Nutrition;2024-08

4. Aberrant DNA methylation associated with the development of metabolic dysfunction-associated fatty liver disease;CHILD`S HEALTH;2024-07-28

5. Fabrication of a Near-Infrared-Emissive Probe for Detecting Dipeptidyl Peptidase 4 in the Liver of Diabetic Mice and Clinical Serum;Analytical Chemistry;2024-07-10